Clinical trial

First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.

NCT03617081

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention NNC0113-2023 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo (NNC0113-2023) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

First Research Study of the Possible New Medicine NNC0113-2023 in Healthy Men.

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-08-09

PhasePHASE1

Conditions

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Interventions

NNC0113-2023DRUG

Placebo (NNC0113-2023)DRUG

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

San AntonioTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03617081 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.